Skip to main content
. 2021 Jul 15;117(1):181–264. [Article in Portuguese] doi: 10.36660/abc.20210180
Renin-angiotensin-aldosterone system inhibitors - Summary of recommendations and evidence
Administer angiotensin-converting enzyme (ACE) inhibitors to intermediate- and high-risk patients with LV dysfunction, high blood pressure, or DM. I A
Administer angiotensin II receptor blockers to intermediate- and high-risk patients with contraindications to ACE inhibitors. I C
Use spironolactone in patients with NSTE-ACS, LVEF ≤ 35%, HF symptoms, or a history of DM. I C
Administer ACE inhibitors to all intermediate- and high-risk patients. IIb B